For Pharma, Trump Vs. Harris Is a Showdown Between Two Industry Foes

[ad_1]

Former President Donald Trump and Vice President Kamala Harris have a rare point of agreement in their otherwise bitter and divisive contest: It’s up to the government to cut high U.S. drug prices. Harris cast the tie-breaking Senate vote in 2022 for legislation that allows Medicare to negotiate drug prices for its more than 60 million beneficiaries. Before that, she was an aggressive regulator…

[ad_2]

Gillian Manning (KFF Health News)

Source link